Search company, investor...

Polyrizon

About Polyrizon

Polyrizon is a private company engaged in developing biological gels for the purpose of protecting patients against biological threats.

Headquarters Location

Israel

Missing: Polyrizon's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Polyrizon's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Polyrizon Patents

Polyrizon has filed 2 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/2/2006

3/25/2014

Epidemiology, Medical specialties, Rare diseases, Bacterial diseases, Nutrition

Grant

Application Date

3/2/2006

Grant Date

3/25/2014

Title

Related Topics

Epidemiology, Medical specialties, Rare diseases, Bacterial diseases, Nutrition

Status

Grant

Latest Polyrizon News

Polyrizon Ltd. Lowers Size of Planned IPO – MarketWatch

Dec 21, 2022

See original article here -> post By Stephen Nakrosis Polyrizon Ltd. lowered the size of its planned initial public offering on Monday from 3.11 million units to 1.35 million units …… Related

Polyrizon Frequently Asked Questions (FAQ)

    Discover the right solution for your team

    The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

    Request a demo

    CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.